Annual Report 2010

• Key Achievements of 2010
• Chairman's Message
• Board of Directors
• Senior Management Messages
  • Chief Executive Officer's Message
  • Chief Operating Officer's Message
  • Chief Financial Officer's Message
  • Chief Legal Counsel's Message
• Building the Future
• Review of Operations
  • Aerospace
  • Capital
  • Energy
  • Healthcare
  • Industry
  • Information & Communications Technology
  • Infrastructure
  • Real Estate & Hospitality
  • Services Ventures
• Key Assets
• Sustainability
• Executive Management
• Consolidated Financial Statements
  • Board of Directors Report
  • Independent Auditors Report
  • Consolidated Statement of Comprehensive Income
  • Statement of Financial Position
  • Consolidated Statement of Changes in Equity
  • Consolidated Statement of Cash Flows
  • Notes to the Consolidated Financial Statements

• Aerospace
• Capital
• Energy
• Healthcare
• Industry
• Information & Communications Technology
• Infrastructure
• Real Estate & Hospitality
• Services Ventures

Useful Tools

Healthcare

The first phase of The National Reference Laboratory was opened at Dubai Technology & Research Park (Dubiotech) in March 2010. The Laboratory, which offers a full range of reference laboratory services, was established to reverse the trend of international send-outs and significantly enhance the region’s healthcare infrastructure. The main regional hub, a larger Abu Dhabi facility, is expected to open in 2011.

Throughout the year, Mubadala Healthcare continued to leverage partnerships with organizations such as Johns Hopkins Medicine International, Imperial College London, and Cleveland Clinic to bring the best of international healthcare expertise to Abu Dhabi.

Further development of Cleveland Clinic Abu Dhabi progressed with the appointment of Sixco-Samsung Joint Venture as the main contractor. The project also received the ‘Best Hospital Design – Built & Future’ award at Hospital Build 2010.

The services of the Imperial College London Diabetes Centre (ICLDC) will expand with the provision of a second facility in Al Ain by the end of 2011. ICLDC treated more than 60,000 patients in 2010 and received certification in the clinical treatment of diabetes mellitus from JCI (Joint Commission International), the global gold standard of hospital excellence. This marks the second accolade for the Centre, following its accreditation in ambulatory care last year.

The opening of the Tawam Molecular Imaging Centre, adjacent to the Tawam Hospital Campus in Al Ain, gave cardiologists, neurologists, and oncologists, throughout the region, access to world-class diagnostic systems and the expertise of clinical operators Johns Hopkins Medicine International.

Abu Dhabi Knee & Sports Medicine Centre carried out 972 surgical procedures in 2010, playing a significant role in treating knee injuries, which are highly prevalent in the region.